AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Brivaracetam 10 Mg ;
17 registrations across 1 African market— 17 active
Markets with Brivaracetam 10 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Pilebriva 10 mg Film Coated Tablets | 🇪🇬Egypt | Hikma Pharmaceuticals industries | active | — |
| Brivapenta Oral Solution | 🇪🇬Egypt | penta pharma egypt | active | — |
| Kativarox 10 mg Film Coated Tablets | 🇪🇬Egypt | Apex pharma | active | — |
| Varocetam 10mg/ml Oral Solution | 🇪🇬Egypt | Gypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTO | active | — |
| Brivaralepsy Oral Solution | 🇪🇬Egypt | PROTECH PHARMACEUTICAL COMPANY | active | — |
| Cetabrivara 10mg Film Coated Tablets | 🇪🇬Egypt | RIVA PHARMA | active | — |
| Convarsiotam Oral Solution | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
| Kativarox Oral Solution | 🇪🇬Egypt | Apex pharma | active | — |
| Brivapenta Oral Solution | 🇪🇬Egypt | penta pharma egypt | active | — |
| Brivafutal Solution For I.V Infusion | 🇪🇬Egypt | FUTURE PHARMACEUTICAL INDUSTRIES-EGYPT | active | — |
| Andolepsy 10mg Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Convarsiotam Oral Solution | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
| Andolepsy 10mg Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Brivaralepsy Oral Solution | 🇪🇬Egypt | PROTECH PHARMACEUTICAL COMPANY | active | — |
| Varocetam 10 mg Film Coated Tablets | 🇪🇬Egypt | Gypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTO | active | — |
| Pilebriva 10 mg Film Coated Tablets | 🇪🇬Egypt | Hikma Pharmaceuticals industries | active | — |
| Convarsiotam 10 mg Film Coated Tablets | 🇪🇬Egypt | Marcyrl pharmaceutical industries - MPI | active | — |
Brivaracetam 10 Mg ; in Africa — Regulatory Overview
Brivaracetam 10 Mg ; is registered across 1 African markets with 17 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 17 registrations, 17 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.